{
    "nctId": "NCT04779450",
    "briefTitle": "Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors",
    "officialTitle": "The Effect of Telemonitoring on Upper Limb Function, Quality of Life and Risk of Lymphedema During and After Pandemic COVID-19 in Women Submitted to Treatment for Breast Cancer: A Randomized Controlled Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Upper Limb Functionality",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age over 18;\n* Diagnosed with breast cancer and submitted to surgical treatment, regardless of the type of surgery;\n* With up to 24 months post-operatively, already completed cycles of adjuvant therapies (radiotherapy and/or chemotherapy);\n* Moderate functional disability with a minimum score of 30% QuickDash questionnaire;\n* Impaired quality of life;\n* Able to understand and access mobile applications or live with someone who assists, has internet access and telephone contact.\n\nExclusion Criteria:\n\n* open lesions;\n* acquired infections;\n* chronic disease or previous motor sequelae that would interfere with participation in the study;\n* women who have difficulty understanding the questions or questionnaires applied or proposed activities;\n* diagnosis of lymphedema;\n* have no functional alterations in the upper limbs or quality of life.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}